If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Issue of Equity

26 Feb 2015 12:09

RNS Number : 9764F
Maven Income & Growth VCT PLC
26 February 2015
 



Joint Announcement

 

Maven VCT Offers for Subscription - Applications for Admission to Listing and Trading

 

Maven Income and Growth VCT plc ("Maven VCT 1"), Maven Income and Growth VCT 2 plc ("Maven VCT 2"), Maven Income and Growth VCT 3 plc ("Maven VCT 3"), Maven Income and Growth VCT 4 plc ("Maven VCT 4") and Maven Income and Growth VCT 5 plc ("Maven VCT 5") (together "the Companies" and each a "Company") are managed by Maven Capital Partners UK LLP ("Maven"). The Boards of the Companies launched offers for subscription to raise, in aggregate, up to £18 million ("the Offers" and each an "Offer"). Full details of the Offers are contained in a prospectus ("the Prospectus"), which was published by the Companies on 20 October 2014.

 

On 20 February 2015, in respect of applications for subscription for the 2014/2015 tax year, each of the Companies announced initial allotments of new Ordinary Shares pursuant to the Offers as follows:

 

Maven VCT 1 - 5,506,387 Ordinary Shares of 10 pence (RNS 5075F)

Maven VCT 2 - 6,125,498 Ordinary Shares of 10 pence (RNS 5076F)

Maven VCT 3 - 4,070,784 Ordinary Shares of 10 pence (RNS 5077F)

Maven VCT 4 - 1,924,909 Ordinary Shares of 10 pence (RNS 5079F)

Maven VCT 5 - 9,155,381 Ordinary Shares of 10 pence (RNS 5081F)

 

The Boards of the Companies expect that allotments in respect of applications for the 2015/2016 tax year will take place in April 2015.

 

In respect of the allotments announced on 20 February 2015, applications have been made by each of the Companies to the UK Listing Authority and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that admission of the new Ordinary Shares of each of the Companies will become effective and dealings will commence on or around 2 March 2015.

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

26 February 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELQLFLELFBBBE
Date   Source Headline
20th May 202610:12 amRNSAdmission of Further Securities to Trading
15th May 202610:45 amRNSDirector/PDMR Shareholding
15th May 202610:41 amRNSIssue of Equity - Dividend Investment Scheme
14th May 20265:22 pmRNSTransaction in Own Shares
12th May 20263:37 pmRNSUnaudited NAV - Dividend Investment Scheme
7th May 20261:45 pmRNSResult of AGM
30th Apr 202610:58 amRNSAdmission of Further Securities to Trading
29th Apr 202612:29 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:27 amRNSAdmission of Further Securities to Trading
14th Apr 202611:09 amRNSIssue of Equity
10th Apr 202612:02 pmRNSUnaudited Net Asset Value
8th Apr 20269:33 amRNSAdmission of Further Securities to Trading
25th Mar 20263:51 pmRNSTransaction in Own Shares
25th Mar 202610:55 amRNSAdmission of Further Securities to Trading
24th Mar 202612:11 pmRNSIssue of Equity
19th Mar 20264:21 pmRNSUnaudited NAV and Proposed Final Dividend
18th Feb 20264:58 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202610:54 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:07 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:52 amRNSDirector/PDMR Shareholding
16th Jan 20269:44 amRNSIssue of Equity
15th Jan 202610:36 amRNSDirector/PDMR Shareholding
15th Jan 202610:35 amRNSDirector/PDMR Shareholding
15th Jan 20269:55 amRNSIssue of Equity
14th Jan 20262:39 pmRNSUnaudited NAV - Dividend Investment Scheme
13th Jan 202612:10 pmRNSUnaudited Net Asset Value
4th Dec 202510:35 amRNSSecond Interim Dividend
18th Nov 20253:48 pmRNSTransaction in Own Shares
14th Nov 20259:31 amRNSNet Asset Value(s)
13th Nov 20254:53 pmRNSResult of General Meeting
2nd Oct 20254:42 pmRNSPublication of a Prospectus
29th Aug 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSIssue of Equity
29th Aug 20257:00 amRNSHalf-year Report
20th Aug 20252:14 pmRNSStatement re Dividend Investment Scheme
31st Jul 20254:42 pmRNSTransaction in Own Shares
16th Jul 202510:18 amRNSStatement re Unaudited NAV and Interim Dividend
16th Jul 20257:08 amRNSStatement re Offer for Subscription
21st May 20254:44 pmRNSTransaction in Own Shares
16th May 20259:30 amRNSDirector/PDMR Shareholding
16th May 20259:26 amRNSIssue of Equity - Dividend Investment Scheme
9th May 20251:53 pmRNSStatement re Dividend Investment Scheme
9th May 202510:03 amRNSNet Asset Value(s)
8th May 20251:43 pmRNSResult of AGM
6th May 202511:55 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.